Position in REPL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$446,796
+$138,354 QoQ
Shares Held
40,361
-45.2% QoQ
Ownership
0.043%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#84
of 199 holders
Holding Since
Dec 2024
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REPL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Exome Asset Management LLC holds $110,788,985 across 37 Biotechnology names. REPL ranks #36 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PRAX |
Praxis Precision Medicines, Inc.
|
27,205 | $9,107,961 | |
| 2 | TGTX |
Tg Therapeutics, Inc.
|
164,915 | $9,060,430 | |
| 3 | COGT |
Cogent Biosciences, Inc.
|
210,523 | $8,147,240 | |
| 4 | IONS |
Ionis Pharmaceuticals Inc
|
88,177 | $6,991,554 | |
| 5 | ABVX |
Abivax S.A.
|
46,878 | $6,246,962 | |
| 6 | ALMS |
Alumis Inc.
|
204,418 | $5,752,322 | |
| 7 | CYTK |
Cytokinetics Inc
|
60,056 | $5,116,170 | |
| 8 | ELVN |
Enliven Therapeutics, Inc.
|
100,203 | $5,085,302 |
All Filings in REPL
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $446,796 | 40,361 | Shares | Sole | 2026-08-14 | |
| 2025-09-30 | $308,442 | 73,614 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,695,989 | 397,846 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $2,874,748 | 294,846 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $662,877 | 54,738 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||